Expression of P2Y6 receptors in microglia increases following transient middle cerebral artery occlusion (tMCAO), and inhibition of P2Y6 receptors with the antagonist MRS2578 suppresses microglial phagocytosis of cell debris, thereby exacerbating neurological deficits (116). Here, P2RY6 is linked to medical procedure.